Vaisakhi Offer- Use Code VAISAKHI24

Register Now

Department of Pharmaceuticals Launches RPTUAS Scheme

Published on March 14, 2024
Current Context: The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has announced the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) Scheme on 11th March 2024.
Department of Pharmaceuticals Launches RPTUAS Scheme
  • This scheme is a significant step in the government’s efforts to upgrade the technological capabilities of the pharmaceutical industry and align it with global standards.
  • Here are some key features of the revised scheme:
    • Broadened Eligibility Criteria: The eligibility for the PTUAS has been expanded beyond Micro, Small and Medium Enterprises to include any pharmaceutical manufacturing unit with a turnover of less than 500 crores that requires technology and quality upgradation.
    • Flexible Financing Options: The scheme introduces more flexible financing options, emphasizing subsidies on a reimbursement basis, over the traditional credit-linked approach.
    • Comprehensive Support for Compliance with New Standards: The scheme now supports a broader range of technological upgrades.
    • Dynamic Incentive Structure: Pharmaceutical units with a certain average turnover for the last three years will be eligible for incentive subject to a maximum of Rs. 1.00 crore per unit.
    • State Government Scheme Integration: The revised scheme allows integration with state government schemes, enabling units to benefit from additional top-up assistance.
    • Enhanced Verification Mechanism: The scheme introduces a robust verification mechanism through a Project Management Agency.
  • This scheme is expected to contribute to industry growth and compliance with global manufacturing standards.
  • It underscores the Government’s commitment to supporting the critical pharmaceutical industry for the nation’s health and well-being.

Question:

Q.1 Who is eligible for the PTUAS under the revised scheme?
a. Only Micro, Small and Medium Enterprises
b. Any pharmaceutical manufacturing unit with a turnover of less than 500 crores
c. Any pharmaceutical manufacturing unit with a turnover of more than 500 crores
d. All of the above
ebook store

About us

ramandeep singh

Ramandeep Singh is a seasoned educator and banking exam expert at BankExamsToday. With a passion for simplifying complex concepts, he has been instrumental in helping numerous aspirants achieve their banking career goals. His expertise and dedication make him a trusted guide in the journey to banking success.

  • Follow me:
Close Menu
Close Menu